ENSAT STAGE III ADRENAL CORTEX CARCINOMA

Clinical trials for ENSAT STAGE III ADRENAL CORTEX CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ENSAT STAGE III ADRENAL CORTEX CARCINOMA trials appear

Sign up with your email to follow new studies for ENSAT STAGE III ADRENAL CORTEX CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Major cancer trial tests aggressive combo to stop rare adrenal Cancer's return

Disease control Recruiting now

This study aims to find the best drug treatment to prevent cancer from returning after surgery for high-risk adrenocortical carcinoma, a rare and aggressive adrenal gland cancer. It will compare a single hormone-blocking drug against that same drug combined with two chemotherapy …

Matched conditions: ENSAT STAGE III ADRENAL CORTEX CARCINOMA

Phase: PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 11, 2026 14:53 UTC

ENSAT STAGE III ADRENAL CORTEX CARCINOMA

Get alerted when new ENSAT STAGE III ADRENAL CORTEX CARCINOMA trials appear

Major cancer trial tests aggressive combo to stop rare adrenal Cancer's return